Covington Capital Management Edwards Lifesciences Corp Transaction History

Covington Capital Management

$23.2 Billion
Q3 2022

A detailed history of Covington Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Covington Capital Management holds 147,307 shares of EW stock, worth $10.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

147,307

Previous 143,562 2.61%

Holding current value

$10.9 Million

Previous $13.7 Million 10.83%

% of portfolio

0.05%

Previous 0.55%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $308,475 - $401,801	3,745 Added 2.61%	147,307 $12.2 Million
Q2 2022 Jul 08, 2022	BUY	$86.5 - $128.27 $423,590 - $628,138	4,897 Added 3.53%	143,562 $13.7 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $2.47 Million - $3.11 Million	24,209 Added 21.15%	138,665 $16.3 Million
Q4 2021 Feb 16, 2022	BUY	$106.37 - $130.68 $599,394 - $736,381	5,635 Added 5.18%	114,456 $14.8 Million
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $662,328 - $790,019	6,436 Added 6.29%	108,821 $12.3 Million
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $563,320 - $703,882	6,719 Added 7.02%	102,385 $10.6 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $1.55 Million - $1.78 Million	19,649 Added 25.85%	95,666 $8 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $85,311 - $108,563	1,190 Added 1.59%	76,017 $6.94 Million
Q3 2020 Nov 16, 2020	SELL	$67.19 - $87.44 $306,386 - $398,726	-4,560 Reduced 5.74%	74,827 $5.97 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $3.2 Million - $4.27 Million	55,548 Added 233.01%	79,387 $5.49 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $30,450 - $47,061	-581 Reduced 2.38%	23,839 $4.5 Million
Q4 2019 Feb 18, 2020	BUY	$71.7 - $82.09 $34,416 - $39,403	480 Added 2.01%	24,420 $5.7 Million
Q3 2019 Nov 18, 2019	BUY	$61.55 - $75.43 $121,869 - $149,351	1,980 Added 9.02%	23,940 $5.27 Million
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $322,734 - $372,933	5,790 Added 35.81%	21,960 $4.06 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $17,719 - $23,698	-370 Reduced 2.24%	16,170 $3.09 Million
Q4 2018 Feb 15, 2019	BUY	$46.41 - $56.94 $120,433 - $147,759	2,595 Added 18.61%	16,540 $2.53 Million
Q3 2018 Nov 15, 2018	BUY	$45.7 - $58.03 $71,292 - $90,526	1,560 Added 12.6%	13,945 $2.43 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $6,579 - $7,951	155 Added 1.27%	12,385 $1.8 Million
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $9,780 - $12,479	-263 Reduced 2.11%	12,230 $1.71 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $60,484 - $70,508	1,790 Added 16.72%	12,493 $1.41 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $26,128 - $27,957	720 Added 7.21%	10,703 $1.17 Million
Q2 2017 Aug 16, 2017	BUY	N/A	9,983	9,983 $1.18 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.7B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Account

Covington Capital Management Edwards Lifesciences Corp Transaction History